rs35480349

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000085.5(CLCNKB):​c.1053+13G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.23 in 1,612,578 control chromosomes in the GnomAD database, including 46,507 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 3664 hom., cov: 33)
Exomes 𝑓: 0.23 ( 42843 hom. )

Consequence

CLCNKB
NM_000085.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.49

Publications

7 publications found
Variant links:
Genes affected
CLCNKB (HGNC:2027): (chloride voltage-gated channel Kb) The protein encoded by this gene is a member of the family of voltage-gated chloride channels. Chloride channels have several functions, including the regulation of cell volume, membrane potential stabilization, signal transduction and transepithelial transport. This gene is expressed predominantly in the kidney and may be important for renal salt reabsorption. Mutations in this gene are associated with autosomal recessive Bartter syndrome type 3 (BS3). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
CLCNKB Gene-Disease associations (from GenCC):
  • Bartter disease type 3
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • Bartter disease type 4B
    Inheritance: AR Classification: STRONG Submitted by: G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Gitelman syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-16050613-G-C is Benign according to our data. Variant chr1-16050613-G-C is described in ClinVar as Benign. ClinVar VariationId is 504914.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.293 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKBNM_000085.5 linkc.1053+13G>C intron_variant Intron 11 of 19 ENST00000375679.9 NP_000076.2
CLCNKBNM_001165945.2 linkc.546+13G>C intron_variant Intron 4 of 12 NP_001159417.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKBENST00000375679.9 linkc.1053+13G>C intron_variant Intron 11 of 19 1 NM_000085.5 ENSP00000364831.5

Frequencies

GnomAD3 genomes
AF:
0.192
AC:
29175
AN:
152058
Hom.:
3653
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0465
Gnomad AMI
AF:
0.424
Gnomad AMR
AF:
0.295
Gnomad ASJ
AF:
0.286
Gnomad EAS
AF:
0.0100
Gnomad SAS
AF:
0.304
Gnomad FIN
AF:
0.227
Gnomad MID
AF:
0.244
Gnomad NFE
AF:
0.249
Gnomad OTH
AF:
0.222
GnomAD2 exomes
AF:
0.239
AC:
59848
AN:
250624
AF XY:
0.243
show subpopulations
Gnomad AFR exome
AF:
0.0424
Gnomad AMR exome
AF:
0.355
Gnomad ASJ exome
AF:
0.288
Gnomad EAS exome
AF:
0.0111
Gnomad FIN exome
AF:
0.220
Gnomad NFE exome
AF:
0.248
Gnomad OTH exome
AF:
0.242
GnomAD4 exome
AF:
0.234
AC:
342230
AN:
1460402
Hom.:
42843
Cov.:
34
AF XY:
0.238
AC XY:
172649
AN XY:
726578
show subpopulations
African (AFR)
AF:
0.0395
AC:
1321
AN:
33458
American (AMR)
AF:
0.347
AC:
15531
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
7438
AN:
26108
East Asian (EAS)
AF:
0.00620
AC:
246
AN:
39700
South Asian (SAS)
AF:
0.309
AC:
26682
AN:
86224
European-Finnish (FIN)
AF:
0.210
AC:
11165
AN:
53112
Middle Eastern (MID)
AF:
0.299
AC:
1722
AN:
5766
European-Non Finnish (NFE)
AF:
0.238
AC:
264416
AN:
1110984
Other (OTH)
AF:
0.227
AC:
13709
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
13211
26422
39632
52843
66054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8818
17636
26454
35272
44090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.192
AC:
29197
AN:
152176
Hom.:
3664
Cov.:
33
AF XY:
0.194
AC XY:
14458
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.0464
AC:
1930
AN:
41552
American (AMR)
AF:
0.296
AC:
4519
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.286
AC:
990
AN:
3464
East Asian (EAS)
AF:
0.0104
AC:
54
AN:
5180
South Asian (SAS)
AF:
0.306
AC:
1478
AN:
4826
European-Finnish (FIN)
AF:
0.227
AC:
2412
AN:
10604
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.248
AC:
16888
AN:
67960
Other (OTH)
AF:
0.224
AC:
472
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1131
2263
3394
4526
5657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.183
Hom.:
624
Bravo
AF:
0.190
Asia WGS
AF:
0.163
AC:
569
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Mar 21, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

c.1053+13G>C in intron 11 of CLCNKB: This variant is not expected to have clinic al significance because it is not located within the splice consensus sequence a nd has been identified in 37.07% (4277/11538) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs35480349) .

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:3
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
11
DANN
Benign
0.38
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35480349; hg19: chr1-16377108; COSMIC: COSV65162263; COSMIC: COSV65162263; API